GENERAL SURGERY

 

Delayed treatment of symptomatic breast cancer: The experience from Kaduna, Nigeria

 

 

A. Y. Ukwenya^I; L. M. D. Yusufu^I; P. T. Nmadu^I; E. S. Garba^II; A. Ahmed^II

^IM.B. B.S., F.M.C.S., F.W.A.C.S.; Department of Surgery, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
^IIM.B. B.S., F.W.A.C.S.; Department of Surgery, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria

 

 

---

SUMMARY

BACKGROUND: A cross-sectional study carried out at a teaching hospital in Kaduna, Nigeria, to investigate the extent and reasons for the delay between onset of symptoms and admission for treatment of symptomatic breast cancer
METHODS: The patients had histologically proven breast cancer and had been admitted for treatment. Data were obtained from interviews and patients' clinical and referral records.
RESULTS: One hundred and eleven consecutive breast cancer patients were interviewed from July 2003 to June 2005. Only 12 (10.8%) could be admitted for treatment within a month of onset of symptoms. Delays were significantly associated with younger patients, elementary or no Western education, and domicile outside the Kaduna metropolitan area. Patients who were referred from, or received initial treatment at, peripheral hospitals had longer delays than those who came for first consultation at the teaching hospital. The proportion of early breast cancer cases (stages I and II) decreased from 45.9% at diagnosis to 25.2% at treatment, as concerns about mastectomy and hospital treatment led a significant number of the patients to temporarily abandon hospital treatment for alternatives, only to return with advanced cancers. The predominant reasons among the 99 patients who had delays of more than a month before admission were: ignorance of the seriousness of a painless breast lump (47.5%), non-acceptance of hospital treatment (46.5%), and preference for traditional treatment (38.4%). A significant number of patients referred from peripheral hospitals had inappropriate surgeries and biopsy management which contributed to the advanced stage on admission.
CONCLUSION: This study shows that delayed treatment of symptomatic breast cancer at this centre in Nigeria is as much related to the quality of medical care as it is to local beliefs, ignorance of the disease, and lack of acceptance of orthodox treatment.

---

 

 

“Full text available only in PDF format”

 

 

REFERENCES

1. Adebamowo CA, Ajayi OO. Breast cancer in Nigeria. West Afr J Med 2000; 19: 179-191.         [ Links ]

2. Chiedozi LC. Rapidly progressing breast cancer in Nigeria. Eur J Surg Oncol 1987; 13: 505-509.         [ Links ]

3. Hassan I, Onukak EE, Mabogunje OA. Breast cancer in Zaria, Nigeria. J R Coli Edinb 1992; 37: 159-161.         [ Links ]

4. Anyawu SN. Survival following treatment of primary breast cancer in eastern Nigeria. East Afr Med J 2000; 77: 539-543.         [ Links ]

5. Anyawu SN. Breast cancer in eastern Nigeria. West Afr J Med 2000; 19: 120-125.         [ Links ]

6. Otu AA, Ekanem IO, Khalil MI, Ekpo MP, Attah EB. Characterization of breast cancer sub groups in an African population. Br J Surg 1989; 76: 182-184.         [ Links ]

7. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999; 79: 858-864.         [ Links ]

8. Afzelius P, Zedeler K, Sommer H, Mouridsen HT Blichert-Toft M. Patient and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol 1994; 33: 345-351.         [ Links ]

9. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer. Lancet 1999; 353: 1119-1126.         [ Links ]

10. Ajekigbe AT. Fear of mastectomy: the most common factor associated with late presentation of carcinoma of the breast in Nigeria. Clin Oncol 1991; 3: 78-80.         [ Links ]

11. Durosinmi-Etti AF. Cancer patients in Nigeria - causes of delay in diagnosis and treatment. Niger Q J Hosp Med 1985; 3: 28-30.         [ Links ]

12. Uche EE. Cancer awareness among a Nigerian population. Trop Doct 1999; 29: 39-40.         [ Links ]

13. Odusanya OO. Breast cancer knowledge, attitudes and practice of female school teachers in Lagos, Nigeria. Breast J 2001; 7: 171-175.         [ Links ]

14. Arndt V, Sturmer T, Stegmaier C, Ziegler H, Becker A, Brennar H. Provider delay among patients with breast cancer in Germany: A population based study. J Clin Oncol 2003; 8: 1440-1446.         [ Links ]

15. Goodsen WH III, Moore DH. Causes of physician delay in diagnosis of breast cancer. Arch Intern Med 2002; 162: 1343-1348.         [ Links ]

16. Gorin SS, Heck JE, Bin Cheng, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 2006; 166: 2244-2252.         [ Links ]

17. Burgess CC, Ramirez AJ, Richards MA, Love SB. Who and what influences delayed presentation in breast cancer? Br J Cancer 1998; 77: 1343-1348.         [ Links ]

18. Gwyn K, Bondy ML, Cohen DS, et al. Racial differences in diagnosis, treatment and clinical delays in a population based study of newly diagnosed breast carcinoma. Cancer 2004; 100: 1595-1604.         [ Links ]

19. Tartter PI, Pace D, Frost M, Bernstein JL. Delay in diagnosis of breast cancer. Ann Surg 1999; 229: 91-96.         [ Links ]

20. Montella M, Crispo A, D'auto G, et al. Determinant factors for diagnostic delay in operable breast cancer patents. Eur J Cancer Prev 2001; 10: 53-59.         [ Links ]

21. Ihekwaba FN. Breast cancer in Nigerian women. Br J Surg 1992; 79: 771-776.         [ Links ]

22. Arndt V, Sturmer T, Steigmaier C, Ziegler H, Dhom G. Brenner H. Patient delay and stage of diagnosis among breast cancers patient in Germany - a population based study. Br J Cancer 2002; 886: 1034-1040.         [ Links ]

23. Lanin DR, Matthews HF, Swanson MJ. Impacting cultural attitudes in African-American women to decrease breast cancer mortality. Am J Surg 2002; 184: 418-423.         [ Links ]

24. Hunter C. Epidemiology, stage at diagnosis and tumor biology of breast cancer in multiracial and multiethnic populations. Cancer 2000; 88: 1193-1202.         [ Links ]

25. Millar BA, Hankey BF, Thomas TL. Impact of sociodemographic factors, hormone receptor status and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 2002; 155: 534-545.         [ Links ]

26. Burgess C, Hunter MS, Ramirez AJ. A qualitative study of delay among women reporting symptoms of breast cancer. Br J Gen Pract 2001; 51: 967-971.         [ Links ]

27. Meechan G, Collins J, Petrie K. Delay in seeking medical care for self-detected breast symptoms in New Zealand Women. N Z Med J 2002; 115: 257.         [ Links ]

28. Hassan I. Cancer of the male breast in Zaria, Nigeria. East Afr Med J 1995; 72: 457-458.         [ Links ]

29. Vorobiof DA, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol 2001; 19: 125-127s.         [ Links ]

30. Odusanya OO, Tayo O. Breast cancer knowledge, attitudes and practice among nurses in Lagos, Nigeria. Acta Oncol 2001; 40: 844-848.         [ Links ]

31. Atoyebi OA, Atimomo CE, Adesanya AA, Beredugo BK, da Rocha-Afodu JT. An appraisal of 100 patients with breast cancer seen at Lagos University Teaching Hospital. Niger Q J Hosp Med 1997; 7: 104-108.         [ Links ]

32. Burstein HJ, Gelber MS, Guadagnoli E, Weeks CJ. Use of alternative medicine by women with early stage breast cancer. N Engl J Med 1999; 340: 1737-1739.         [ Links ]

33. Wright SV. An investigation into the causes of absconding black African breast cancer patients. S Afr Med J 1997; 87: 1540-1543.         [ Links ]